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Short summary 26 
Little is known about the long-term renal sequelae of AKI requiring dialysis, 27 
especially in patients who recover sufficient kidney function. We examined the 28 
long-term renal outcome among hospitalised patients who sustained AKI 29 
requiring acute dialysis, and had normal renal function 12 months or later after 30 
the episode of AKI, to help determine if this group of patients merits long-term 31 
follow-up of kidney function. Our data suggest that these patients have a low 32 
risk for CKD with a greater risk associated with increasing age, diabetes, and 33 
vascular comorbidity. Unless otherwise requiring follow up of renal function for 34 
comorbid conditions, patients who recover to eGFR >60mL/min/1.73m2 by 12 35 
months after an episode of dialysis-requiring AKI have very little to gain from 36 
ongoing monitoring of renal function. 37 
 38 
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Abstract 49 
Background: 50 
Severe acute kidney injury (AKI) among hospitalised patients often 51 
necessitates initiation of short-term dialysis. Little is known about the long-52 
term outcome of those who recover to normal renal function. The aim of this 53 
study was to determine the long-term renal outcome of patients experiencing 54 
AKI requiring dialysis secondary to hypoperfusion injury and/or sepsis who 55 
recovered to apparently normal renal function. 56 
Methods: 57 
All adult patients with AKI requiring dialysis in our centre between January 1, 58 
1980, and December 31, 2010, were identified. We included patients who had 59 
estimated glomerular filtration rate (eGFR) greater than 60mL/min/1.73m2 12 60 
months or later after the episode of AKI. Patients were followed up until March 61 
3, 2015. The primary outcome was time to chronic kidney disease (CKD) 62 
(defined as eGFR persistently <60mL/min/1.73m2) from first dialysis for AKI. 63 
Results: 64 
Among 2,922 patients with a single episode of dialysis-requiring AKI, 396 65 
patients met the study inclusion criteria. The mean age was 49.8 (SD 16.5) 66 
years and median follow-up was 7.9 (IQR 4.8-12.7) years. Thirty-five (8.8%) 67 
of the patients ultimately developed CKD after a median of 5.3 (IQR 2.8-8.0) 68 
years from first dialysis for AKI giving an incidence rate of 1 per 100 person-69 
years. Increasing age, diabetes and vascular disease were associated with 70 
higher risk of progression to CKD [adjusted hazard ratios (95% CI); 1.06 71 
(1.03, 1.09), 3.05 (1.41, 6.57) and 3.56 (1.80, 7.03) respectively].  72 
Conclusions: 73 
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Recovery from AKI necessitating in-hospital dialysis was associated with a 74 
very low risk of progression to CKD. Most of the patients who progressed to 75 
CKD had concurrent medical conditions meriting monitoring of renal function. 76 
Therefore, it seems unlikely that regular follow-up of renal function is 77 
beneficial in patients who recover to eGFR >60mL/min/1.73m2 by 12 months 78 
after an episode of AKI. 79 
 80 
Abbreviations: 81 
AKI, acute kidney injury 82 
CKD, chronic kidney disease 83 
CKD-EPI, chronic kidney disease epidemiology collaboration  84 
eGFR, estimated glomerular filtration rate 85 
ESRD, end stage renal disease 86 
HD, haemodialysis 87 
HIV, human immunodeficiency virus 88 
HR, hazard ratio 89 
ICU, intensive care unit 90 
IQR, interquartile range 91 
NICE, national institute for health and care excellence 92 
RRT, renal replacement therapy 93 
SD, standard deviation 94 
TMA, thrombotic microangiopathy 95 
 96 
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 98 
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Introduction 99 
Severe acute kidney injury (AKI) requiring initiation of dialysis is associated 100 
with in-hospital mortality rates from 45% to 60%1-3. Among those who survive, 101 
as many as 15% require dialysis at the time of discharge1,4. 102 
Little is known about the long-term sequelae of AKI requiring in-hospital 103 
dialysis, especially in patients who recover sufficient kidney function. Reports 104 
of long-term renal function in survivors of dialysis-requiring AKI are sparse 105 
and only a few studies have observed patients for more than 1 year5,6. In a 106 
recent prospective study of 19 survivors of AKI needing dialysis, 60% of 107 
participants did not have any reduction of kidney function and only one patient 108 
required maintenance haemodialysis after 5 years7. Recently, there has been 109 
increasing recognition that patients with AKI with apparent complete recovery 110 
remain at risk for long-term renal complications8-10 and may benefit from 111 
longitudinal follow-up for primary chronic kidney disease (CKD) prevention. 112 
Current guidelines suggest that people should be monitored for the 113 
development of CKD for at least 2-3 years after AKI, even if serum creatinine 114 
has returned to baseline11. 115 
This study aimed to examine the long-term renal outcome among hospitalised 116 
patients who sustained AKI requiring acute dialysis i.e. the severest form of 117 
AKI, and had normal renal function 12 months or later after the episode of 118 
AKI, to help determine if this group of patients merits long-term follow-up of 119 
kidney function.  120 
 121 
Subjects and Methods 122 
Design and Participants 123 
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This was a single-centre population-based cohort study of all adult patients in 124 
our catchment area (serving a population of approximately 1.5 million), with 125 
AKI who required in-hospital dialysis in the nephrology unit. We identified all 126 
adults aged 18 years and older who had a first episode of dialysis-requiring 127 
AKI between January 1, 1980 and December 31, 2010 through a structured 128 
query language interrogation from the prospectively maintained electronic 129 
patient record. We included patients who had an estimated glomerular 130 
filtration rate (eGFR) greater than 60mL/min/1.73m2 at least 12 months after 131 
the index hospitalisation discharge. We excluded individuals with underlying 132 
nephropathy (glomerulonephritis, vasculitis with kidney involvement, 133 
haemolytic-uremic syndrome, polycystic kidney disease, and multiple 134 
myeloma), receipt of a kidney transplant, dialysis specifically for drug toxicity, 135 
or more than one episode of dialysis-requiring AKI.  136 
 137 
Baseline Data 138 
Age, sex, aetiology of AKI, admission in intensive care unit (ICU) before 139 
transfer to the renal unit, duration of dialysis, length of hospital admission, and 140 
the presence of comorbidity prior to the index hospitalisation admission date 141 
(diabetes, vascular disease, and heart failure) were recorded. Vascular 142 
disease included documented coronary artery disease, peripheral vascular 143 
disease or cerebrovascular disease. 144 
We also retrieved data on the last serum creatinine prior to the index 145 
hospitalisation (if it was known), serum creatinine on admission and discharge 146 
from hospital, the first serum creatinine recorded 12 months after the episode 147 
of AKI and subsequent serum creatinine levels up to the last creatinine 148 
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recorded in the system. Our electronic patient record automatically imports all 149 
subsequent lab results from the point of installation of a patient at the time of 150 
referral thus allowing complete capture of results for analysis even if the 151 
patient is not attending the renal services. 152 
Follow-up data included early nephrology clinic appointment defined as a visit 153 
with a nephrologist within 90 days of hospital discharge. For the patients that 154 
developed CKD, follow-up data in any outpatient clinics for comorbid 155 
conditions were retrieved. 156 
Causes of AKI included decreased effective plasma volume (volume 157 
contraction, heart failure, hypotension, and cardiac arrest), sepsis, 158 
medication-related, radiocontrast media, post-operative, and others (mainly 159 
rhabdomyolysis, acute pancreatitis, suspected thrombotic microangiopathy, 160 
and uncertain aetiology). 161 
Comorbidities were defined as follows: (1) diabetes - if a patient had ever 162 
required hypoglycaemic agents or insulin or when the diagnosis had been 163 
noted in the medical records; (2) coronary artery disease - documented 164 
coronary stenosis by angiography or history of myocardial infarction or 165 
previous coronary revascularization by angioplasty, stenting, or bypass 166 
surgery; (3) peripheral vascular disease - history of lower extremity 167 
revascularization or digit or extremity amputation or when the diagnosis had 168 
been noted in the medical records; (4) cerebrovascular disease – history of 169 
stroke or transient ischemic attack documented by computed tomography 170 
scan, magnetic resonance imaging, or when the diagnosis had been noted in 171 
the medical records; and (5) heart failure - classic signs and symptoms and 172 
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either documentation by echocardiography or when the diagnosis had been 173 
noted in the medical records. 174 
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation 175 
was used for estimation of eGFR12. 176 
 177 
Outcome Assessment 178 
Patients were tracked for outcomes beginning 12 months after hospital 179 
discharge. The main study outcome was progression to CKD from first 180 
dialysis for AKI. This was defined as the date of the first sustained drop in 181 
eGFR defined as two outpatient eGFR of <60mL/min/1.73m2 at least 90 days 182 
apart. Normal renal function was defined as an outpatient eGFR of 183 
≥60mL/min/1.73m2 in at least one occasion 1 year or later after the episode of 184 
AKI. 185 
 186 
Statistical Analyses 187 
We examined differences in demographic and clinical factors, stratified by 188 
ever progressing to CKD or not. Continuous variables were expressed with 189 
means and standard deviations or medians and interquartile ranges (for non-190 
parametric data), and compared by Student’s t-test or Mann-Whitney U test 191 
as appropriate. Categorical variables were reported as frequencies and 192 
percentages and proportions compared by chi-squared test or Fisher’s exact 193 
test. 194 
Incidence rates of progression to CKD were determined for study participants. 195 
Because of the very long inclusion period of 30 years, we also compared 196 
outcomes in three eras: 1980–1990, 1991-2000 and 2001–2010. Mean eGFR 197 
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on admission, discharge, 12 months after the AKI, and at time of last 198 
creatinine recorded between patients that progressed to CKD and patients 199 
with normal renal function were compared by t-test. 200 
Time-to-event analysis was performed until March 3, 2015 by Kaplan-Meier 201 
estimate with time to CKD as the outcome variable. Follow-up was censored 202 
at the date of the last serum creatinine recorded before March 3, 2015. 203 
Univariate analysis was performed to test the association of baseline 204 
variables with future CKD. Statistically significant variables were tested in a 205 
Cox proportional hazards model with time from first dialysis for AKI to 206 
progression to CKD as the dependent variable. 207 
For all analyses, a p value <0.05 was considered significant. The IBM SPSS 208 
Statistics Package (version 21.0; SPSS, Inc., Armonk, NY) was used for all 209 
analyses. 210 
 211 
Results 212 
Study population 213 
We identified 396 individuals with AKI requiring dialysis who had normal renal 214 
function 12 months after the episode of AKI and fulfilled the study entry 215 
criteria. For 552 patients, no creatinine measurements were recorded at 1 216 
year or later after the episode of AKI therefore an outcome could not be 217 
ascertained (lost to follow up) (Figure 1). 218 
The mean age of the enrolled participants was 49.8 [standard deviation (SD) 219 
16.5] years, 34.8% were women and the median length of index hospital 220 
admission was 13 [interquartile range (IQR) 9-20] days. 13.4% of participants 221 
had documented diabetes and 18.2% had vascular disease in the period 222 
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before the index hospital admission. During hospitalisation, 25.0% of patients 223 
with AKI requiring dialysis received ICU care before transfer to the renal unit. 224 
More than a quarter of participants had sepsis and 110 (27.8%) patients had 225 
multifactorial AKI. Fewer than half of the patients were followed up in the 226 
nephrology clinic within 90 days after discharge from the index admission 227 
(Table 1). 228 
 229 
Progression to CKD 230 
Thirty-five (8.8%) of the patients ultimately developed CKD after a median of 231 
5.3 (IQR 2.8-8.0) years from first dialysis for AKI giving an incidence rate of 232 
progression to CKD of 1 per 100 person-years. 233 
At the end of follow-up, eGFR was >60mL/min/1.73m2 in 361 (91.2%) 234 
patients, 45-60mL/min/1.73m2 in 21 (5.3%), 30-44.9mL/min/1.73m2 in 12 235 
(3.0%) and 15-29.9mL/min/1.73m2 in 2 (0.5%) patients. None of the patients 236 
developed CKD stage 5 or end stage renal disease (ESRD) (Figure 2). 113 237 
(28.5%) patients died during the duration of follow-up. 238 
Renal function gradually improved for the patients that maintained normal 239 
function in the long-term and gradually declined after the first year for the 240 
patients that progressed to CKD (Figure 3). Mean eGFR at discharge was 241 
higher for the patients that progressed to CKD. Although mean eGFR was 242 
>60mL/min/1.73m2 at 1 year for both groups, patients that progressed to CKD 243 
had significantly lower eGFR at this time point (69.8 vs 84.3mL/min/1.73m2, 244 
p<0.001) (Figure 3). 245 
By Kaplan-Meier analysis, the probabilities of progression to CKD were 2.6% 246 
at 5 years, 11.1% at 10 years, and 23.4% at 20 years (Figure 4). From the 247 
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patients that developed CKD, 23 (65.7%) had diabetes, vascular disease or 248 
heart failure and 7 (20.0%) had other medical conditions (i.e. chronic 249 
obstructive pulmonary disease, inflammatory bowel disease, liver cirrhosis 250 
etc.) requiring regular follow-up. 251 
 252 
Predictors of progression to CKD 253 
Univariate analysis for progression to CKD demonstrated age [hazard ratio 254 
(HR) 1.07 per year increase; p<0.001], the presence of diabetes (HR 5.54; 255 
p<0.001) and vascular disease (HR 6.60; p<0.001) as independent predictors 256 
of progression to CKD. Due to the small number of CKD events, only 3 257 
independent variables were tested in the proportional hazards regression 258 
model for multivariate analysis. By multivariate analysis age (HR 1.06; 259 
p<0.001), the presence of diabetes (HR 3.05; p=0.005) and vascular disease 260 
(HR 3.56; p<0.001) were also independent predictors of progression to CKD 261 
(Table 2). There was no association between sex, early nephrology follow up 262 
or the decade of AKI occurrence and progression to CKD. 263 
 264 
Discussion 265 
Our findings expand on prior knowledge to provide clinicians with new 266 
information about the long-term effect of dialysis-requiring AKI. The data 267 
suggest that patients who recover from severe AKI have a low risk for CKD 268 
and ESRD. The relationship between AKI and CKD varied, with a greater risk 269 
associated with increasing age, diabetes, and vascular comorbidity. Normal 270 
renal function at 1 year after the episode of AKI predicted a favourable long-271 
term renal outcome. Strict adherence to current UK National Institute for 272 
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Health and Care Excellence (NICE) guidelines11 will lead to unnecessary 273 
follow-up for the majority of patients recovering from AKI. 274 
Due in part to the aging population, the incidence of AKI is increasing and is 275 
expected to double over the next decade13. Follow-up of all patients to detect 276 
the development of CKD and attempt to mitigate the risks of poor long-term 277 
outcomes requires staff resources, nephrologists’ time, and patient time to 278 
attend clinic visits; therefore, these costs should be justified by demonstrable 279 
clinical benefits and there is no high quality evidence so far to prove that this 280 
will reduce morbidity or mortality. An unequivocal association between AKI 281 
and CKD/ESRD has been documented in a number of large, well-conducted 282 
studies14 and a recent meta-analysis15, but none of these studies focused on 283 
determining this relationship in patients who recover to normal renal function 284 
long after AKI. In a study looking at the long-term consequences of AKI in 285 
human immunodeficiency virus (HIV)-infected persons, recovery from 286 
moderate-severe AKI markedly diminished the relationship between AKI and 287 
ESRD (those with recovery had a 2-fold risk for ESRD vs. a 10-fold risk 288 
among those without recovery)16.  289 
The question is therefore which survivors of AKI warrant follow-up, who 290 
should follow these patients up and for how long. A multi-site clinical trial 291 
(NCT02483039) in Canada is currently recruiting adult AKI survivors to 292 
determine if structured post-AKI follow-up can improve outcomes compared to 293 
usual care, however it will take some time to have the same length of follow-294 
up as we have in this study. 295 
Other data suggest that risk of progression to CKD may diminish over time17 296 
and when CKD develops after AKI, it occurs relatively early within the first 297 
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three to six months after hospital discharge9. Therefore, six months appears 298 
to be the minimum period of time during which kidney function should be 299 
monitored, with 12 months providing more reassurance that new or 300 
accelerated CKD will not be missed. 301 
Interestingly, in this study eGFR at discharge did not predict long-term 302 
outcome as patients who subsequently developed CKD had higher eGFR at 303 
discharge. Sarcopenia is common in hospitalised acutely ill patients ranging 304 
from 10 to 40% and is associated with older age, prolonged hospital stay and 305 
adverse health outcomes18-20. This makes creatinine-based eGFR at 306 
discharge difficult to interpret as a higher eGFR may reflect loss of muscle 307 
mass and poor nutritional status. The same may hold true even a year after 308 
hospital discharge, especially for older AKI survivors and may be a 309 
confounder. Future studies using cystatin C derived eGFR, which is less 310 
dependent on muscle mass, may be more informative21. 311 
Several studies have previously evaluated the outcomes of survivors of AKI 312 
requiring dialysis; however they often include patients with pre-existing CKD 313 
and patients who died or progressed to CKD or ESRD shortly following 314 
discharge. Wald et al found that 3,769 individuals with AKI requiring dialysis 315 
who survived free of dialysis for at least 30 days after discharge had a three-316 
fold increased risk of ESRD compared with 13,598 matches without AKI after 317 
a median follow-up of 3 years. Interestingly, the risk of chronic dialysis was 15 318 
times higher when only patients without previous CKD were included in 319 
analysis22. Harel et al. showed that nephrology follow-up within 90 days of 320 
dialysis-requiring AKI was associated with a 24% lower risk of death at 2 321 
years compared to patients who did not receive nephrology follow-up. 322 
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Subjects with follow-up were more likely to progress to chronic dialysis, 323 
although they had a higher likelihood of having pre-existing CKD23. In another 324 
retrospective study of more than 100,000 ICU patients with or without pre-325 
existing CKD in Sweden, the 5-year risk of progression to ESRD was 25.5% 326 
in the group of patients with acute on CKD, followed by 21.1% in the CKD 327 
group without AKI and 3.9% in the AKI group24. Comparable to our findings, 328 
recovery of renal function at 90 days after the AKI event was associated with 329 
4 times lower probability of progression to CKD after a median follow-up of 2.8 330 
years in a study of 3,231 participants with AKI25. 331 
Studies assessing the risk of developing CKD have to take into account the 332 
association between CKD and age, and an estimate of the background 333 
population risk of developing CKD is essential to interpret results. The 334 
estimated probability of progression to CKD after an episode of dialysis-335 
requiring AKI was 23.4% at 20 years and this is similar to the prevalence of 336 
CKD in the general population for age-matched individuals. For example, 337 
large population studies have shown a prevalence of >35% for CKD stage 3-4 338 
combined after the age of 70 years in US26, and a prevalence of CKD stage 3-339 
5 of 18% for males and 28% for females aged between 65 and 74 in UK27. It 340 
is therefore plausible that progression to CKD after prolonged follow-up 341 
relates to age, as well as to the common ancestors of both AKI and CKD, 342 
including a host of diverse metabolic and vascular abnormalities, rather than a 343 
direct consequence of previous AKI. The association of progression to CKD 344 
with vascular comorbid conditions supports this hypothesis, i.e. the patients 345 
may well have developed CKD, even without having had an episode of AKI. In 346 
a recent study of 1,067 patients with AKI necessitating renal replacement 347 
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therapy stratified by the presence of comorbidity, 10-year rates of progression 348 
to ESRD were 24.0% and 7.1% in patients with and without comorbidity, 349 
respectively28.  350 
In our study, 85.7% patients who progressed to CKD were already followed by 351 
multiple specialists for competing health problems and had regular blood tests 352 
including monitoring of renal function. The rest 14.3% had mean age of 68.4 353 
years at time of CKD and mean eGFR of 47mL/min/1.73m2 at time of last 354 
creatinine recorded. None of these patients had eGFR of less than 355 
30mL/min/1.73m2 at the end of follow-up. Thus we contend that these patients 356 
do not need nephrology follow-up after the first year, but should be referred to 357 
nephrology for assessment if CKD develops. 358 
Both human and animal studies have shown that a variety of intrinsic repair 359 
processes involving a host of growth factors and proliferative and other 360 
signalling cascades are activated rapidly after kidney injury29,30. Sustained 361 
recovery might be attributed to adaptive repair, whereas progression may be 362 
secondary to maladaptive repair processes31. Several pathophysiologic 363 
processes constitute maladaptive repair with the potential to promote 364 
interstitial fibrosis. For example, ischemia-reperfusion injury promotes the loss 365 
of renal vasculature, a reduction in the number of functioning nephrons, and 366 
progressive renal fibrosis32,33. Hence, evaluation of biomarkers indicative of 367 
adaptive and maladaptive repair represents the key to identify these patients 368 
who are most susceptible to progression. We have shown that serum 369 
creatinine concentration (and subsequent estimation of eGFR) at 1 year after 370 
the episode of AKI may provide a predictive insight as to the long-term 371 
consequences of AKI. 372 
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The strengths of this study include the rigorous assessments of recovery from 373 
AKI and progression to CKD by using outpatient creatinine measurements 374 
and actual creatinine changes instead of diagnostic codes. Also, the study 375 
population, which was a cohort of low risk individuals with inclusion only of 376 
patients that recovered to normal renal function, and the long duration of 377 
follow-up. Finally, only patients with dialysis-requiring AKI admitted to the 378 
renal unit were included to reduce potential selection bias. 379 
The main limitation of our study is the single-center study design which limits 380 
generalisability, so direct inferences must be interpreted in the context of the 381 
demographics of our study population. That said, in our cohort the patients 382 
were relatively young (mean age of 50 years) with low burden of comorbidity 383 
(13% diabetics and 18% vasculopaths) which is to be expected, as older, frail 384 
patients are less likely to survive long following an episode of AKI. Outcomes 385 
may have been influenced by centre-specific factors including time of initiation 386 
of dialysis following severe AKI, selection of patients for nephrology follow up 387 
and duration of follow up, and therapeutic interventions implemented to 388 
control blood pressure and proteinuria. Due to its retrospective design 389 
potential confounders may have not been recorded, though data were 390 
collected contemporaneously in the electronic record. Some data elements of 391 
interest may not be available in retrospective studies. It would have been 392 
interesting to analyse measures of kidney health other than serum creatinine 393 
at 1 year such as urinalysis, urine albumin to creatinine ratio, renal ultrasound 394 
and measurement of systolic and diastolic blood pressure but analysis was 395 
limited by missing data. To minimise selection bias, we only included patients 396 
who received dialysis within our renal unit. Nonetheless, some selection bias 397 
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may have occurred due to loss to follow-up as patients with fewer comorbid 398 
conditions and normal renal function in the long-term were less likely to get 399 
continued monitoring of their renal function. This may have overestimated the 400 
effect of dialysis-requiring AKI on the development of future CKD. Since the 401 
present study features a long inclusion period, practices may have changed 402 
substantially over this time period and this might have influenced our findings. 403 
Therefore, we analysed different eras but were unable to detect any era 404 
effect. The absence of a comparator group in our study prevents one from 405 
determining the degree to which AKI and dialysis is a predictor for long-term 406 
renal function in excess of global patient comorbidity before and during the 407 
index hospitalisation. We did not retrieve data on subsequent episodes of 408 
non-dialysis-requiring AKI, which are associated with increased risk for 409 
developing CKD.  410 
 411 
Conclusions 412 
We have shown that recovery of renal function is a prognosticator of good 413 
long-term renal outcome in the most severe cases of AKI. If patients with AKI 414 
requiring dialysis survive to 12 months following onset of AKI and their renal 415 
function is normal, the risk of progression to CKD over the next 10 years is 416 
very low. Patients who would not otherwise require follow up of renal function 417 
for comorbid conditions have very little to gain from ongoing monitoring of 418 
renal function. 419 
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Table 1 
Patients who recovered from dialysis-requiring acute kidney injury, stratified by progression to chronic kidney disease 
 All patients 
(n=396) 
CKD (n=35) No CKD 
(n=361) 
p-valuea 
Age, mean (SD) 49.8 (16.5) 60.8 (11.6) 48.8 (16.5) <0.001 
Male sex, n (%) 258 (65.2) 22 (62.9) 236 (65.4) 0.83 
Comorbidity 
Diabetes, n (%) 
Vascular disease (coronary artery disease, cerebrovascular 
disease, peripheral vascular disease), n (%) 
Heart failure, n (%) 
None of the above, n (%) 
 
53 (13.4) 
 
72 (18.2) 
10 (2.5) 
283 (71.5) 
 
11 (31.4) 
 
17 (48.6) 
3 (8.6) 
12 (34.3) 
 
42 (11.6) 
 
55 (15.2) 
7 (1.9) 
271 (75.1) 
 
0.005 
 
<0.001 
0.04 
0.006 
Cause of AKI 
Decreased renal perfusion (volume contraction, heart failure, 
hypotension, cardiac arrest), n (%) 
Sepsis, n (%) 
Medication-related, n (%) 
Radiocontrast media, n (%) 
 
 
103 (19.3) 
143 (26.7) 
78 (14.6) 
5 (0.9) 
 
 
13 (25.0) 
15 (28.9) 
13 (25.0) 
1 (1.9) 
 
 
90 (18.6) 
128 (26.5) 
65 (13.5) 
4 (0.8) 
 
 
0.32 
0.78 
0.06 
1.00 
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Post-operative, n (%) 
Others [rhabdomyolysis (n=94), acute pancreatitis (n=17), 
suspected TMA (n=12), acute liver failure (n=8), obstructive 
uropathy (n=4), pregnancy related (n=3), hypercalcaemia (n=1), 
tumour lysis syndrome (n=1), unclear (n=27)], n (%) 
39 (7.3) 
 
 
 
167 (31.2) 
5 (9.6) 
 
 
 
5 (9.6) 
34 (7.0) 
 
 
 
162 (33.6) 
0.60 
 
 
 
0.004 
Era of AKI 
1980 to 1990 
1991 to 2000 
2001 to 2010 
 
126 (31.8) 
110 (27.8) 
160 (40.4) 
 
9 (25.8) 
13 (37.1) 
13 (37.1) 
 
117 (32.4) 
97 (26.9) 
147 (40.7) 
 
0.53 
0.32 
0.78 
Days on dialysis, median (IQR) 6 (3-11) 5 (2-9) 6 (3-11) 0.14 
Length of admission, days; median (IQR) 13 (9-20) 12 (7-20) 14 (9-20) 0.38 
Admission in ICU, n (%) 99 (25.0) 9 (25.7) 90 (24.9) 1.00 
eGFR at hospital discharge, mL/min/1.73m2; 
mean (SD) 
<15, n (%) 
15-29, n (%) 
30-59, n (%) 
≥60, n (%) 
 
30.0 (22.3) 
116 (29.3) 
128 (32.3) 
108 (27.3) 
44 (11.1) 
 
37.9 (23.7) 
7 (20.0) 
5 (14.3) 
16 (45.7) 
7 (20.0) 
 
29.3 (22.1) 
109 (30.2) 
123 (34.1) 
92 (25.5) 
37 (10.2) 
 
0.03 
0.32 
0.06 
0.05 
0.12 
Early nephrology outpatient follow up, n (%) 163 (41.2) 11 (31.4) 152 (42.1) 0.40 
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Died, n (%) 113 (28.5) 16 (45.7) 97 (26.9) 0.05 
Follow-up, yr; median, (IQR) 7.9 (4.8-
12.7) 
8.0 (5.1-9.9) 7.9 (4.8-
12.9) 
0.41 
a t-test or chi-squared test or Mann-Whitney U test where appropriate 
CKD, chronic kidney disease; SD, standard deviation; AKI, acute kidney injury; IQR, interquartile range; ICU, intensive care unit; 
eGFR, estimated glomerular filtration rate; TMA, thrombotic microangiopathy. 
 
 
 
 
Table 2 
Factors associated with progression to chronic kidney disease 
Factor Univariate analysis Multivariate analysis 
Hazard ratio (95% CI) p-value Hazard ratio (95% CI) p-value 
Age, per year increase 1.07 (1.04-1.10) <0.001 1.06 (1.03-1.09) <0.001 
Diabetes 5.54 (2.60-11.80) <0.001 3.05 (1.41-6.57) 0.005 
Vascular disease 6.60 (3.37-12.89) <0.001 3.56 (1.80-7.03) <0.001 
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Legends to figures 
 
Figure 1. Creation of the dialysis-requiring acute kidney injury study cohort. 
HD, haemodialysis; ESRD, end stage renal disease; AKI, acute kidney injury; 
RRT; renal replacement therapy; eGFR, estimated glomerular filtration rate.  
 
Figure 2. Long-term renal function after recovery from dialysis-requiring 
acute kidney injury. 
eGFR, estimated glomerular filtration rate; AKI, acute kidney injury. 
 
Figure 3. Estimated mean GFR and standard deviation in patients that 
progressed to chronic kidney disease vs. those that maintained normal renal 
function. The difference in eGFR was statistically significant at discharge from 
hospital, at 1 year after the episode of acute kidney injury and at the time of 
last creatinine recorded.  
eGFR, estimated glomerular filtration rate; CKD, chronic kidney disease; AKI, 
acute kidney injury; sCr, serum Creatinine. 
 
Figure 4. Kaplan-Meier plot of time to progression to chronic kidney disease 
1 year after an episode of dialysis-requiring acute kidney injury.  
CKD, chronic kidney disease; AKI, acute kidney injury.
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3232 Patients had at least one dialysis session 
January 1980-December 2010
2922 With a single episode of HD for AKI
1975 Survived at 1 year
435 Normal renal function at 1 year
396 Included in analysis
39 Excluded
24 Underlying glomerular disease
15 Dialysis for drug overdose
1540 Excluded
112 On RRT at 1 year
552 Lost to follow up at 1 year
876 eGFR<60mL/min/173m2 at 1 year
947 Died
600 Died during index 
hospitalisation
347 Died within the first year after 
discharge 
310 Excluded
307 Had HD for ESRD
3 Had previous AKI requiring HD
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